Department of Pediatrics, Army Hospital (Research & Referral), New Delhi, 110010, India.
Indian J Pediatr. 2018 Jan;85(1):1-4. doi: 10.1007/s12098-017-2457-3. Epub 2017 Sep 9.
To assess the dynamics of the onset of antipyretic efficacy of intravenous (IV) acetaminophen vs. oral (PO) acetaminophen in the management of fever in children.
This observational single-dose study was conducted at Department of Pedriatrics, Army Hospital (Research and Referral), a multispecialty tertiary care center in New Delhi in fever patients to assess the antipyretic efficacy of IV acetaminophen 15 mg/kg/dose vs. PO acetaminophen 15 mg/kg/dose over 6 h. Subjects were randomly assigned to receive either IV acetaminophen (n = 200) or PO acetaminophen (n = 200).
Demographics and baseline characteristics were similar between the two groups and were normally distributed. Allergic reaction was found in 7 (3.5%) patients in IV acetaminophen group and was absent in PO acetaminophen group. Onset of constipation and dry mouth was found in 8 patients (4%) in IV acetaminophen group and was absent in PO acetaminophen group. Additional dose was required in 6 patients (3%) in intravenous acetaminophen group and 10 patients (5%) in oral acetaminophen group respectively. Statistically significant differences in the rate of fall in temperature through 180 min were observed in favor of the IV acetaminophen group when compared to those receiving PO acetaminophen.
A single dose of intravenous acetaminophen is safe and effective in reducing fever where patients are unable to tolerate oral administration or when rapid reduction of temperature is desirable.
评估静脉(IV)与口服(PO)对乙酰氨基酚在儿童发热管理中退热效果的出现动态。
本观察性单剂量研究在新德里的一家多专科三级保健中心——陆军医院(研究和转诊)儿科进行,评估 IV 对乙酰氨基酚 15mg/kg/剂量与 PO 对乙酰氨基酚 15mg/kg/剂量在 6 小时内的退热效果。受试者被随机分配接受 IV 对乙酰氨基酚(n=200)或 PO 对乙酰氨基酚(n=200)。
两组的人口统计学和基线特征相似,呈正态分布。IV 对乙酰氨基酚组有 7 例(3.5%)出现过敏反应,PO 对乙酰氨基酚组无过敏反应。IV 对乙酰氨基酚组有 8 例(4%)出现便秘和口干,PO 对乙酰氨基酚组无便秘和口干。IV 对乙酰氨基酚组需要额外剂量的有 6 例(3%),PO 对乙酰氨基酚组有 10 例(5%)。与接受 PO 对乙酰氨基酚的患者相比,接受 IV 对乙酰氨基酚的患者在 180 分钟内体温下降的速度有统计学显著差异。
在患者无法耐受口服给药或需要快速降温时,单次静脉注射对乙酰氨基酚是安全有效的退热方法。